Hospital
South Nassau Communities Hospital
South Nassau Communities Hospital was paid $49.46M by Medicaid between Jan 2018 and Dec 2024, across 317 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 14% of everything it billed.
33Billing provider infoSOUTH NASSAU COMMUNITIES HOSPITAL
OCEANSIDE, NY 11572
OCEANSIDE, NY 11572
33aNPI1922079094assigned 01/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$49.46M
24GClaims863,683
24DCodes billed317
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#31 of 231
Median peer was paid$561K
This provider vs. median88×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,613 | $714K | |
| 2019 | 61,607 | $3.29M | |
| 2020 | 142,482 | $8.25M | |
| 2021 | 171,218 | $9.92M | |
| 2022 | 168,698 | $10.03M | |
| 2023 | 173,494 | $10.05M | |
| 2024incomplete | 129,571 | $7.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 14% | 45,510 | 36,823 | $6.88M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 35,999 | 34,259 | $6.61M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 6.9% | 21,592 | 9,460 | $3.43M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 28,740 | 24,649 | $2.97M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.3% | 14,278 | 13,570 | $2.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 11,293 | 10,869 | $2.02M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.4% | 2,943 | 1,267 | $1.20M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.3% | 8,901 | 4,859 | $1.12M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 5,951 | 5,819 | $1.08M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.0% | 7,826 | 7,044 | $999K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 4,719 | 4,644 | $975K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 7,173 | 6,683 | $739K |
305 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 31,717 | $666K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 5,760 | $650K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.2% | 9,280 | $616K |
| 93975 | 1.2% | 1,641 | $585K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 931 | $544K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 1,553 | $531K |
| G0378 | Hospital observation service, per hour | 1.0% | 1,021 | $503K |
| 59025 | Fetal non-stress test | <1% | 2,586 | $446K |
| 36415 | Collection of venous blood by venipuncture | <1% | 51,446 | $439K |
| 86885 | <1% | 9,997 | $406K | |
| 76818 | <1% | 3,061 | $387K | |
| 80061 | Lipid panel | <1% | 8,032 | $364K |
| 76641 | <1% | 2,467 | $357K | |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 2,058 | $350K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,732 | $348K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,862 | $333K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,649 | $331K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,726 | $324K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,795 | $321K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,416 | $318K |
| 86901 | <1% | 12,464 | $313K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,150 | $307K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 5,382 | $293K |
| 93458 | <1% | 193 | $292K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,741 | $272K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 3,216 | $272K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,348 | $271K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,831 | $265K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,269 | $255K |
| 86900 | <1% | 12,470 | $251K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,336 | $247K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 310 | $233K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,185 | $218K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 302 | $204K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,591 | $200K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,489 | $198K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 19,503 | $190K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 932 | $184K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,349 | $176K |
| 76801 | <1% | 1,834 | $172K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,332 | $165K |
| 82607 | <1% | 2,764 | $148K | |
| 99051 | <1% | 7,876 | $126K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,315 | $124K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 6,572 | $120K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,535 | $119K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,488 | $119K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,032 | $115K |
| 76820 | <1% | 1,625 | $109K | |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 1,129 | $107K |
| 96367 | <1% | 884 | $107K | |
| 86803 | <1% | 1,613 | $104K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,079 | $98K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,768 | $93K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,897 | $89K |
| 76821 | <1% | 1,351 | $89K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,569 | $88K |
| 93325 | <1% | 802 | $88K | |
| 87428 | <1% | 4,489 | $86K | |
| 12001 | <1% | 264 | $86K | |
| 82746 | <1% | 1,748 | $83K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,135 | $82K |
| 96376 | <1% | 1,520 | $79K | |
| 86480 | <1% | 896 | $76K | |
| 84466 | <1% | 1,819 | $74K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,002 | $73K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,568 | $71K |
| T1030 | Nursing care, in the home, by registered nurse, per diem | <1% | 525 | $71K |
| 82728 | <1% | 1,946 | $67K | |
| 83880 | <1% | 2,654 | $65K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,454 | $63K |
| 99441 | <1% | 455 | $61K | |
| 80047 | <1% | 3,654 | $59K | |
| 83655 | <1% | 1,410 | $54K | |
| 90715 | <1% | 2,256 | $51K | |
| 86920 | <1% | 866 | $50K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 121 | $48K |
| 76813 | <1% | 566 | $48K | |
| 90686 | <1% | 2,974 | $48K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13,010 | $48K |
| 80076 | <1% | 3,802 | $47K | |
| 93970 | <1% | 116 | $47K | |
| 90670 | <1% | 1,915 | $46K | |
| 85027 | <1% | 6,811 | $43K | |
| 90461 | <1% | 1,477 | $42K | |
| 81025 | <1% | 9,189 | $39K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,832 | $39K |
| 81001 | <1% | 13,619 | $38K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,878 | $37K |
| 84439 | <1% | 1,351 | $37K | |
| 77336 | <1% | 119 | $36K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 306 | $36K |
| 93976 | <1% | 96 | $34K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,447 | $31K |
| 87340 | <1% | 1,879 | $29K | |
| 96415 | <1% | 52 | $28K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,187 | $27K |
| 12011 | <1% | 81 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,053 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 573 | $24K |
| 76825 | <1% | 106 | $24K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 169 | $23K |
| 88142 | <1% | 545 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,585 | $23K |
| 83540 | <1% | 1,823 | $23K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 2,174 | $23K |
| 93971 | <1% | 415 | $21K | |
| 88304 | <1% | 769 | $21K | |
| 82043 | <1% | 382 | $21K | |
| 88307 | <1% | 340 | $21K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,811 | $20K |
| 77065 | Tomosynthesis, mammo | <1% | 199 | $20K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 116 | $20K |
| 85610 | <1% | 12,781 | $19K | |
| 90680 | <1% | 1,724 | $19K | |
| 90648 | <1% | 1,804 | $19K | |
| 90677 | <1% | 419 | $19K | |
| 86706 | <1% | 746 | $18K | |
| 84702 | <1% | 1,896 | $18K | |
| 0002A | <1% | 483 | $17K | |
| 92558 | <1% | 312 | $17K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 29 | $16K |
| 93017 | <1% | 91 | $16K | |
| 77290 | <1% | 32 | $16K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,396 | $15K |
| 90723 | <1% | 1,363 | $14K | |
| 88342 | <1% | 527 | $14K | |
| 0001A | <1% | 476 | $14K | |
| 83970 | <1% | 174 | $13K | |
| 93296 | <1% | 468 | $13K | |
| 83615 | <1% | 1,186 | $13K | |
| 86592 | <1% | 2,060 | $12K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,602 | $12K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $12K |
| 99442 | <1% | 75 | $11K | |
| 85730 | <1% | 4,231 | $11K | |
| 83735 | <1% | 2,310 | $10K | |
| 82248 | <1% | 1,197 | $10K | |
| 76827 | <1% | 107 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,747 | $10K |
| 86140 | <1% | 1,250 | $10K | |
| 90633 | <1% | 809 | $10K | |
| 86704 | <1% | 190 | $9K | |
| 84436 | <1% | 1,428 | $9K | |
| 84484 | <1% | 9,715 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 238 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 416 | $9K |
| 82570 | <1% | 848 | $9K | |
| 97802 | <1% | 142 | $8K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 155 | $8K |
| 77300 | <1% | 16 | $8K | |
| S9484 | Crisis intervention mental health services, per hour | <1% | 65 | $7K |
| 86762 | <1% | 362 | $7K | |
| 82550 | <1% | 7,084 | $7K | |
| 81002 | <1% | 5,118 | $6K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 224 | $6K |
| 84153 | <1% | 202 | $5K | |
| 84479 | <1% | 930 | $5K | |
| 77066 | Tomosynthesis, mammo | <1% | 38 | $5K |
| 83690 | <1% | 7,632 | $5K | |
| 82784 | <1% | 83 | $5K | |
| 31575 | <1% | 14 | $5K | |
| 85652 | <1% | 729 | $5K | |
| 83020 | <1% | 137 | $5K | |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 19 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,257 | $5K |
| 84480 | <1% | 226 | $5K | |
| 90710 | <1% | 333 | $4K | |
| 82247 | <1% | 453 | $4K | |
| 86765 | <1% | 64 | $4K | |
| 86141 | <1% | 27 | $4K | |
| 86038 | <1% | 132 | $4K | |
| 86255 | <1% | 16 | $4K | |
| 87070 | <1% | 2,066 | $4K | |
| 82150 | <1% | 4,908 | $4K | |
| 36430 | <1% | 12 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,372 | $3K |
| 93304 | <1% | 12 | $3K | |
| 84100 | <1% | 1,190 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 108 | $3K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 34 | $3K |
| 88141 | <1% | 147 | $3K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 97 | $3K |
| J3490 | Unclassified drugs | <1% | 2,644 | $3K |
| 73562 | <1% | 828 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,054 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 82 | $3K |
| 77334 | <1% | 18 | $3K | |
| 0012A | <1% | 113 | $3K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 37 | $3K |
| 81003 | <1% | 642 | $3K | |
| 85379 | <1% | 2,072 | $3K | |
| 83605 | <1% | 6,961 | $2K | |
| 87631 | <1% | 68 | $2K | |
| 87186 | <1% | 430 | $2K | |
| 87040 | <1% | 4,283 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,523 | $2K |
| 85651 | <1% | 455 | $2K | |
| 0011A | <1% | 116 | $2K | |
| 29125 | <1% | 14 | $2K | |
| 73030 | <1% | 644 | $2K | |
| 99443 | <1% | 12 | $2K | |
| 85007 | <1% | 855 | $2K | |
| 90656 | <1% | 149 | $2K | |
| 85018 | <1% | 525 | $2K | |
| 97161 | <1% | 13 | $2K | |
| 85014 | <1% | 524 | $2K | |
| 82962 | <1% | 513 | $2K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 81 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,014 | $2K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 59 | $2K |
| 86735 | <1% | 40 | $1K | |
| 80306 | <1% | 2,298 | $1K | |
| 82553 | <1% | 2,318 | $1K | |
| 82378 | <1% | 32 | $1K | |
| 84703 | <1% | 1,560 | $1K | |
| 80320 | <1% | 2,917 | $1K | |
| 88112 | <1% | 12 | $1K | |
| 90698 | <1% | 90 | $1K | |
| 82950 | <1% | 139 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,222 | $1K |
| 72100 | <1% | 697 | $1K | |
| 84145 | <1% | 75 | $1K | |
| 87486 | <1% | 47 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,868 | $1K |
| 99152 | <1% | 164 | $1K | |
| 86787 | <1% | 61 | $975.87 | |
| 88313 | <1% | 12 | $961.48 | |
| 87088 | <1% | 325 | $941.72 | |
| 93321 | <1% | 82 | $916.42 | |
| 76870 | <1% | 26 | $877.84 | |
| 90649 | <1% | 20 | $868.00 | |
| 90700 | <1% | 94 | $741.02 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 56 | $736.56 |
| 87581 | <1% | 47 | $731.48 | |
| 82948 | <1% | 884 | $715.52 | |
| 84156 | <1% | 160 | $714.95 | |
| C1769 | Guide wire | <1% | 28 | $653.46 |
| C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away | <1% | 74 | $605.82 |
| 96040 | <1% | 14 | $604.70 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,223 | $596.80 |
| 73130 | <1% | 436 | $577.42 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 804 | $575.83 |
| 90734 | <1% | 14 | $570.35 | |
| 73610 | <1% | 851 | $554.56 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 26 | $550.26 |
| 73080 | <1% | 15 | $534.00 | |
| 0004A | <1% | 14 | $511.04 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13,188 | $476.22 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,396 | $466.58 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 31 | $442.01 |
| 87081 | <1% | 86 | $435.23 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 69 | $417.93 |
| 73630 | <1% | 898 | $350.42 | |
| 87420 | <1% | 146 | $337.46 | |
| 94760 | <1% | 68 | $318.29 | |
| 90685 | <1% | 169 | $300.79 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,019 | $294.11 |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away | <1% | 69 | $287.32 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,563 | $279.47 |
| 80329 | <1% | 1,893 | $278.94 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | <1% | 12 | $272.55 |
| 90661 | <1% | 12 | $268.52 | |
| 86769 | <1% | 19 | $264.31 | |
| 84550 | <1% | 67 | $213.77 | |
| C1765 | Adhesion barrier | <1% | 79 | $172.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 64 | $169.10 |
| 73110 | <1% | 151 | $168.59 | |
| 74018 | <1% | 41 | $166.34 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,353 | $159.67 |
| A4649 | Surgical supply; miscellaneous | <1% | 427 | $150.89 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,254 | $142.26 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 409 | $135.17 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,651 | $113.40 |
| 87660 | <1% | 13 | $98.07 | |
| 87510 | <1% | 13 | $98.07 | |
| 87480 | <1% | 13 | $98.07 | |
| 87077 | <1% | 79 | $83.77 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,288 | $81.66 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 248 | $70.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,515 | $64.67 |
| 82105 | <1% | 13 | $49.34 | |
| 85045 | <1% | 27 | $49.27 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 73 | $35.42 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,427 | $19.69 |
| 88300 | <1% | 16 | $12.35 | |
| 87205 | <1% | 38 | $10.20 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 589 | $8.34 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 42 | $7.69 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 18 | $7.49 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 22 | $6.99 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 285 | $5.99 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 317 | $2.48 |
| 3077F | <1% | 29 | $0.04 | |
| 3079F | <1% | 15 | $0.03 | |
| 99080 | 0% | 1,273 | $0.00 | |
| 73590 | 0% | 25 | $0.00 | |
| 73140 | 0% | 41 | $0.00 | |
| 82805 | 0% | 12 | $0.00 | |
| 88302 | 0% | 13 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 201 | $0.00 |
| 74022 | 0% | 101 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 14 | $0.00 |
| 73090 | 0% | 27 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARMA, ADHI (PRESIDENT)